Brief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
12/10/2026 22:37
BRIEF-Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results Oct 12 (Reuters) - Organogenesis Holdings Inc. ORGO.O:
ORGANOGENESIS ANNOUNCES PUBLICATION OF PEER-REVIEWED PREPARE TRIAL RESULTS DEMONSTRATING CLINICAL BENEFIT OF PURAPLY®AM FOR HARD-TO-HEAL DIABETIC FOOT ULCERS
Source text: ID:nGNXbxmNk9
Further company coverage: ORGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers